Organizations are pursuing various approaches to control mosquitos harboring dengue and Zika viruses, Technology Review reports.
Researchers at Smith College used NGS and a Galaxy-based software called RepeatExplorer to design improved assays for soil-transmitted helminths.
Affymetrix has created a new custom genotyping array for the project, which aims to increase rice production for small farms in Africa and Asia.
The company is currently in discussions with several investor groups and plans to use the funds to expand the reach of the test and prepare for FDA submission.
Intended for diagnosing active pulmonary tuberculosis, the test will use Cere's Nanotrap reagents for enriching target analytes for downstream analysis.
Three philanthropies have teamed up on a new program to support early career researchers in the biomedical sciences.
Cepheid is now considering adapting TB tests in development to cover the mutations, an executive told GenomeWeb.
With the additional funding, Sera aims to develop new tests for predicting the risk of preterm birth in women in developing countries, the company said.
The data repository of tuberculosis drug susceptibility will spur diagnostic assay development; access will be open to partner firms in one year.
The Paul G. Allen Family Foundation and the Bill & Melinda Gates Foundation awarded the grant to Cepheid to develop the test.
Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.
Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.
The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.
In Science this week: genetically modified flu virus could be key to new live vaccines, and more.